Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $969.54 | 50 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $225.19 | 12 | $0 (2024) |
| Novo Nordisk Inc | $121.98 | 6 | $0 (2024) |
| ABBVIE INC. | $110.57 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $91.11 | 5 | $0 (2024) |
| PFIZER INC. | $64.28 | 4 | $0 (2024) |
| Amgen Inc. | $57.74 | 2 | $0 (2024) |
| ViiV Healthcare Company | $54.79 | 3 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $48.82 | 3 | $0 (2023) |
| Exact Sciences Corporation | $45.94 | 2 | $0 (2024) |
| Lilly USA, LLC | $35.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $509.47 | 25 | AstraZeneca Pharmaceuticals LP ($158.42) |
| 2023 | $202.16 | 11 | AstraZeneca Pharmaceuticals LP ($52.36) |
| 2022 | $214.71 | 11 | SANOFI-AVENTIS U.S. LLC ($32.22) |
| 2021 | $43.20 | 3 | Merck Sharp & Dohme Corporation ($28.79) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: Bone Health | ||||||
| 09/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Obesity | ||||||
| 08/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: Respiratory | ||||||
| 07/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Obesity | ||||||
| 06/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: PAIN | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Respiratory | ||||||
| 05/31/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: HIV | ||||||
| 05/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: VACCINE | ||||||
| 05/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Obesity | ||||||
| 03/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Respiratory | ||||||
| 03/22/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardiology | ||||||
| 03/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: PAIN | ||||||
| 03/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Oncology | ||||||
| 02/29/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: HIV | ||||||
| 02/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Respiratory | ||||||
| 02/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: VACCINE | ||||||
| 01/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $2.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 397 | 459 | $78,825 | $14,623 |
| 2022 | 2 | 26 | 27 | $5,570 | $1,162 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 124 | $29,760 | $5,458 | 18.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 58 | 79 | $26,860 | $3,833 | 14.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 66 | $11,220 | $2,799 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 31 | 31 | $6,850 | $1,263 | 18.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 30 | 30 | $1,200 | $482.10 | 40.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 20 | 20 | $800.00 | $321.40 | 40.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 12 | 13 | $325.00 | $123.76 | 38.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 29 | 33 | $330.00 | $123.20 | 37.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 17 | $1,020 | $120.00 | 11.8% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 30 | 34 | $340.00 | $58.59 | 17.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 12 | $120.00 | $40.92 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $3,360 | $625.92 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $2,210 | $536.25 | 24.3% |
About Paige Vetrano, PA-C
Paige Vetrano, PA-C is a Physician Assistant healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2021. The National Provider Identifier (NPI) number assigned to this provider is 1326712266.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Paige Vetrano, PA-C has received a total of $969.54 in payments from pharmaceutical and medical device companies, with $509.47 received in 2024. These payments were reported across 50 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($969.54).
As a Medicare-enrolled provider, Vetrano has provided services to 423 Medicare beneficiaries, totaling 486 services with total Medicare billing of $15,785. Data is available for 2 years (2022–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Providence, RI
- Active Since 08/04/2021
- Last Updated 10/05/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1326712266
Products in Payments
- FARXIGA (Drug) $99.32
- AIRSUPRA (Drug) $86.98
- Wegovy (Drug) $79.16
- NURTEC ODT (Drug) $66.77
- UBRELVY (Drug) $62.28
- DOVATO (Drug) $54.79
- TOUJEO (Biological) $48.82
- QULIPTA (Drug) $48.29
- GARDASIL (Biological) $47.20
- Cologuard Collection Kit (Device) $45.94
- GARDASIL 9 (Biological) $43.91
- BREZTRI (Drug) $38.89
- JARDIANCE (Drug) $35.00
- EVENITY (Biological) $28.92
- Repatha (Biological) $28.82
- Ozempic (Drug) $24.12
- GVOKE PFS (Drug) $19.18
- Saxenda (Drug) $18.70
- TRELEGY ELLIPTA (Drug) $18.49
- Arikayce (Drug) $15.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Providence
Mr. Thomas Bales, Pa-C, PA-C
Physician Assistant — Payments: $17,581
Mrs. Amanda Matteson, Pa-C, PA-C
Physician Assistant — Payments: $8,188
Paige Lovelace, Pa-C, PA-C
Physician Assistant — Payments: $6,850
James Noon
Physician Assistant — Payments: $5,562
Helen Nguyen, Pa-C, PA-C
Physician Assistant — Payments: $4,500
Mark Trott, Pa, PA
Physician Assistant — Payments: $3,858